Sclerosing Agent [EPC]

Sclerosing Agent [EPC] was reported 450 times

These side effects are most commonly reported by patients taking drugs of the Sclerosing Agent [EPC] class:

# Drug class Count
0 DEEP VEIN THROMBOSIS 35
1 PAIN 28
2 PRURITUS 28
3 OFF LABEL USE 27
4 ERYTHEMA 26
5 DIZZINESS 24
6 SWELLING 24
7 INJECTION SITE PAIN 23
8 PAIN IN EXTREMITY 23
9 NAUSEA 22
10 URTICARIA 22
11 DRUG INEFFECTIVE 20
12 SKIN DISCOLOURATION 19
13 PULMONARY EMBOLISM 18
14 HYPERSENSITIVITY 17
15 FATIGUE 15
16 HEADACHE 15
17 PYREXIA 15
18 RASH 15
19 MALAISE 14
20 HYPOAESTHESIA 13
21 HYPOTENSION 13
22 CHEST PAIN 12
23 INJECTION SITE ERYTHEMA 12
24 VOMITING 12
25 APHASIA 11
26 DYSPNOEA 11
27 FALL 11
28 VERTIGO 11
29 ASTHENIA 10
30 BLISTER 10
31 BURNING SENSATION 10
32 COLITIS 10
33 INJECTION SITE URTICARIA 10
34 CARDIAC ARREST 9
35 CONTUSION 9
36 DIARRHOEA 9
37 HYPERTENSION 9
38 PERIPHERAL SWELLING 9
39 SKIN NECROSIS 9
40 CHEST DISCOMFORT 8
41 DECREASED APPETITE 8
42 FEELING ABNORMAL 8
43 HYPOCALCAEMIA 8
44 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8
45 INJECTION SITE DISCOLOURATION 8
46 ISCHAEMIC STROKE 8
47 PALPITATIONS 8
48 PARAESTHESIA 8
49 RASH MACULO-PAPULAR 8
50 SKIN ULCER 8
51 ULCER 8
52 CHILLS 7
53 DYSGEUSIA 6
54 FLUSHING 6
55 HEART RATE INCREASED 6
56 INJECTION SITE SWELLING 6
57 OEDEMA 6
58 PARAESTHESIA ORAL 6
59 PRODUCT USE IN UNAPPROVED INDICATION 6
60 TENDERNESS 6
61 ADVERSE EVENT 5
62 ANAPHYLACTIC REACTION 5
63 ARTHRALGIA 5
64 CELLULITIS 5
65 GAIT DISTURBANCE 5
66 HAEMATOMA 5
67 HEMIPARESIS 5
68 INJECTION SITE WARMTH 5
69 LIMB DISCOMFORT 5
70 LOSS OF CONSCIOUSNESS 5
71 NODULE 5
72 PETECHIAE 5
73 RECTAL HAEMORRHAGE 5
74 VISION BLURRED 5
75 WOUND 5
76 ABDOMINAL PAIN 4
77 ANAPHYLACTIC SHOCK 4
78 BACK PAIN 4
79 DEHYDRATION 4
80 DRUG INTERACTION 4
81 DYSPEPSIA 4
82 EXTRAVASATION 4
83 HYPERTHYROIDISM 4
84 HYPOKINESIA 4
85 INJECTION SITE BRUISING 4
86 LEFT VENTRICULAR DYSFUNCTION 4
87 OVERDOSE 4
88 PHLEBITIS 4
89 PURPURA 4
90 RASH ERYTHEMATOUS 4
91 STRESS CARDIOMYOPATHY 4
92 TACHYCARDIA 4
93 WEIGHT DECREASED 4
94 ADVERSE DRUG REACTION 3
95 ARTERIAL THROMBOSIS 3
96 BLOOD PRESSURE DECREASED 3
97 BRADYCARDIA 3
98 CARDIO-RESPIRATORY ARREST 3
99 CEREBRAL GAS EMBOLISM 3
100 CONDITION AGGRAVATED 3
101 CONFUSIONAL STATE 3
102 COUGH 3
103 DERMATITIS ALLERGIC 3
104 FEELING HOT 3
105 GASTRITIS 3
106 HYPOAESTHESIA ORAL 3
107 HYPOVOLAEMIC SHOCK 3
108 INJECTION SITE INDURATION 3
109 INJECTION SITE MASS 3
110 INJECTION SITE NECROSIS 3
111 INJECTION SITE ULCER 3
112 MACULAR DEGENERATION 3
113 MUSCULOSKELETAL STIFFNESS 3
114 NECROSIS 3
115 PANCREATITIS 3
116 PERIPHERAL COLDNESS 3
117 PRESCRIBED UNDERDOSE 3
118 RENAL IMPAIRMENT 3
119 SCAB 3
120 SUPERFICIAL VEIN THROMBOSIS 3
121 SYNCOPE 3
122 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
123 THERAPEUTIC RESPONSE DECREASED 3
124 THROMBOPHLEBITIS SUPERFICIAL 3
125 TINNITUS 3
126 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 3
127 ABDOMINAL DISTENSION 2
128 ABDOMINAL PAIN UPPER 2
129 ABNORMAL SENSATION IN EYE 2
130 ACCIDENTAL EXPOSURE TO PRODUCT 2
131 ACNE 2
132 ADMINISTRATION SITE EXTRAVASATION 2
133 ALLERGIC GRANULOMATOUS ANGIITIS 2
134 ANAEMIA 2
135 ARRHYTHMIA 2
136 ASTHMA 2
137 ATRIAL FIBRILLATION 2
138 BLEEDING VARICOSE VEIN 2
139 CHRONIC SINUSITIS 2
140 CIRCULATORY COLLAPSE 2
141 COLITIS ISCHAEMIC 2
142 COLITIS ULCERATIVE 2
143 CONSTIPATION 2
144 COORDINATION ABNORMAL 2
145 DERMATITIS 2
146 DRUG ADMINISTRATION ERROR 2
147 DRUG ERUPTION 2
148 DRUG HYPERSENSITIVITY 2
149 DYSARTHRIA 2
150 ECCHYMOSIS 2
151 EMBOLIA CUTIS MEDICAMENTOSA 2
152 EXPOSURE DURING PREGNANCY 2
153 FEMALE GENITAL TRACT FISTULA 2
154 FOETAL EXPOSURE DURING PREGNANCY 2
155 FREQUENT BOWEL MOVEMENTS 2
156 GENERAL PHYSICAL HEALTH DETERIORATION 2
157 HAEMATOCHEZIA 2
158 HYPERCALCAEMIA 2
159 HYPERKALAEMIA 2
160 HYPOXIA 2
161 INFECTION 2
162 INFLUENZA LIKE ILLNESS 2
163 INFUSION RELATED REACTION 2
164 INJECTION SITE HYPOAESTHESIA 2
165 INJECTION SITE INFECTION 2
166 INJECTION SITE OEDEMA 2
167 INJECTION SITE PRURITUS 2
168 INJECTION SITE REACTION 2
169 INJECTION SITE THROMBOSIS 2
170 INJECTION SITE VESICLES 2
171 INSOMNIA 2
172 ISCHAEMIA 2
173 LIVER FUNCTION TEST ABNORMAL 2
174 MENISCUS INJURY 2
175 MIGRAINE 2
176 MYOCARDIAL INFARCTION 2
177 NEPHROCALCINOSIS 2
178 NERVE INJURY 2
179 NEURALGIA 2
180 OEDEMA PERIPHERAL 2
181 ORAL CANDIDIASIS 2
182 OROPHARYNGEAL DISCOMFORT 2
183 PALLOR 2
184 PANCREATITIS ACUTE 2
185 PANCYTOPENIA 2
186 PARADOXICAL EMBOLISM 2
187 PEMPHIGOID 2
188 PERIPHERAL EMBOLISM 2
189 PERIPHERAL ISCHAEMIA 2
190 PERIPHERAL VENOUS DISEASE 2
191 PHLEBITIS DEEP 2
192 PNEUMONIA 2
193 PORTAL HYPERTENSION 2
194 POST PROCEDURAL CONTUSION 2
195 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2
196 PRESYNCOPE 2
197 PROCEDURAL PAIN 2
198 PROCTITIS 2
199 PRODUCT USE ISSUE 2
200 PSORIASIS 2
201 PULSE ABSENT 2
202 RADICULOPATHY 2
203 RASH MACULAR 2
204 REBOUND EFFECT 2
205 RESPIRATORY DISTRESS 2
206 SEPTIC SHOCK 2
207 SKIN EXFOLIATION 2
208 SKIN HYPERPIGMENTATION 2
209 SKIN IRRITATION 2
210 SKIN LESION 2
211 SKIN REACTION 2
212 SNEEZING 2
213 SOFT TISSUE NECROSIS 2
214 SOMNOLENCE 2
215 SPEECH DISORDER 2
216 SWELLING OF EYELID 2
217 TENDONITIS 2
218 THROMBOPHLEBITIS 2
219 TRANSIENT ISCHAEMIC ATTACK 2
220 UNEVALUABLE EVENT 2
221 VAGINAL DISCHARGE 2
222 VAGINAL FLATULENCE 2
223 VENOUS THROMBOSIS 2
224 VISUAL IMPAIRMENT 2
225 WHITE BLOOD CELL COUNT INCREASED 2
226 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
227 ABASIA 1
228 ABDOMINAL PAIN LOWER 1
229 ABORTION INDUCED 1
230 ACUTE ABDOMEN 1
231 ACUTE CORONARY SYNDROME 1
232 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1
233 ACUTE KIDNEY INJURY 1
234 ACUTE MYOCARDIAL INFARCTION 1
235 ADMINISTRATION SITE DISCOLOURATION 1
236 AGITATION 1
237 ALANINE AMINOTRANSFERASE INCREASED 1
238 ALTERED STATE OF CONSCIOUSNESS 1
239 AMNESIA 1
240 AMPUTATION 1
241 ANAL SPHINCTER ATONY 1
242 ANAPHYLACTOID SHOCK 1
243 ANGINA PECTORIS 1
244 ANGIODERMATITIS 1
245 ANGIOEDEMA 1
246 ANORECTAL DISORDER 1
247 APPLICATION SITE PAIN 1
248 APPLICATION SITE RASH 1
249 APPLICATION SITE ULCER 1
250 APPLICATION SITE WOUND 1
251 ARTERIOSPASM CORONARY 1
252 ARTHRITIS 1
253 ASCITES 1
254 B-CELL LYMPHOMA 1
255 BILIARY DYSKINESIA 1
256 BLADDER DYSFUNCTION 1
257 BLEPHAROCHALASIS 1
258 BLEPHAROSPASM 1
259 BLINDNESS 1
260 BLISTER RUPTURE 1
261 BLOOD BILIRUBIN INCREASED 1
262 BLOOD BLISTER 1
263 BLOOD IMMUNOGLOBULIN M INCREASED 1
264 BLOOD LACTATE DEHYDROGENASE INCREASED 1
265 BLOOD PRESSURE ABNORMAL 1
266 BLOOD THYROID STIMULATING HORMONE INCREASED 1
267 BLUE TOE SYNDROME 1
268 BONE PAIN 1
269 BOWEL MOVEMENT IRREGULARITY 1
270 BRAIN FOG 1
271 BREAST INDURATION 1
272 BREAST INFLAMMATION 1
273 BRONCHITIS CHRONIC 1
274 BUNDLE BRANCH BLOCK LEFT 1
275 C-REACTIVE PROTEIN INCREASED 1
276 CARDIAC FLUTTER 1
277 CATARACT 1
278 CENTRAL NERVOUS SYSTEM LESION 1
279 CEREBRAL ARTERY OCCLUSION 1
280 CEREBRAL INFARCTION 1
281 CEREBROVASCULAR ACCIDENT 1
282 CHEST WALL ABSCESS 1
283 CHOLANGITIS 1
284 CHOLELITHIASIS 1
285 COLD SWEAT 1
286 COLOSTOMY 1
287 COMA 1
288 CONTRAINDICATED PRODUCT ADMINISTERED 1
289 COR PULMONALE ACUTE 1
290 CYANOSIS 1
291 CYST 1
292 CYTOKINE RELEASE SYNDROME 1
293 DEAFNESS 1
294 DEATH 1
295 DECREASED NASOLABIAL FOLD 1
296 DEPRESSED LEVEL OF CONSCIOUSNESS 1
297 DEPRESSED MOOD 1
298 DEPRESSION 1
299 DERMATITIS BULLOUS 1
300 DERMATITIS PSORIASIFORM 1
301 DIABETES MELLITUS 1
302 DIABETIC NEUROPATHY 1
303 DILATED CARDIOMYOPATHY 1
304 DISCOMFORT 1
305 DISSEMINATED INTRAVASCULAR COAGULATION 1
306 DIZZINESS POSTURAL 1
307 DRUG EFFECT LESS THAN EXPECTED 1
308 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
309 DYSSTASIA 1
310 ECZEMA 1
311 ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION 1
312 EMBOLISM 1
313 ENTEROCOCCAL SEPSIS 1
314 EPIDERMAL NECROSIS 1
315 EPILEPSY 1
316 EPISTAXIS 1
317 ERYTHEMA NODOSUM 1
318 EXPIRED PRODUCT ADMINISTERED 1
319 EXTRAPYRAMIDAL DISORDER 1
320 EYE IRRITATION 1
321 EYE MOVEMENT DISORDER 1
322 EYELID OEDEMA 1
323 FACIAL PARALYSIS 1
324 FACIAL PARESIS 1
325 FAECES DISCOLOURED 1
326 FEMORAL NECK FRACTURE 1
327 FLANK PAIN 1
328 FOETAL DEATH 1
329 GAIT INABILITY 1
330 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
331 GASTRIC DISORDER 1
332 GASTRIC ULCER 1
333 GASTROENTERITIS VIRAL 1
334 GASTROINTESTINAL HYPOMOTILITY 1
335 GASTROINTESTINAL NECROSIS 1
336 GASTROINTESTINAL PAIN 1
337 GENITAL RASH 1
338 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
339 GRANULOMA ANNULARE 1
340 GRANULOMATOUS LYMPHADENITIS 1
341 GROIN PAIN 1
342 HAEMATURIA 1
343 HAEMOGLOBIN DECREASED 1
344 HAEMOLYTIC ANAEMIA 1
345 HAEMORRHAGIC OVARIAN CYST 1
346 HAEMOSIDERIN STAIN 1
347 HEMIANOPIA HOMONYMOUS 1
348 HEMIPLEGIA 1
349 HEPATIC PAIN 1
350 HEPATIC STEATOSIS 1
351 HEPATITIS 1
352 HEPATOMEGALY 1
353 HERPES SIMPLEX 1
354 HERPES ZOSTER 1
355 HYPERBILIRUBINAEMIA NEONATAL 1
356 HYPERCAPNIA 1
357 HYPERGLYCAEMIA 1
358 HYPERHIDROSIS 1
359 HYPERSENSITIVITY VASCULITIS 1
360 HYPERSOMNIA 1
361 HYPOCHROMIC ANAEMIA 1
362 HYPOKALAEMIA 1
363 HYPOPNOEA 1
364 IMMUNE SYSTEM DISORDER 1
365 IMMUNE THROMBOCYTOPENIA 1
366 IMMUNODEFICIENCY COMMON VARIABLE 1
367 IMPAIRED HEALING 1
368 INCOHERENT 1
369 INCONTINENCE 1
370 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
371 INDURATION 1
372 INFLAMMATORY MARKER INCREASED 1
373 INJECTION RELATED REACTION 1
374 INJECTION SITE CELLULITIS 1
375 INJECTION SITE HAEMATOMA 1
376 INJECTION SITE INFLAMMATION 1
377 INJECTION SITE INJURY 1
378 INJECTION SITE IRRITATION 1
379 INJECTION SITE SCAB 1
380 INTESTINAL RESECTION 1
381 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 1
382 JAUNDICE 1
383 JOINT SWELLING 1
384 LACRIMATION DECREASED 1
385 LEG AMPUTATION 1
386 LIMB MASS 1
387 LIP OEDEMA 1
388 LIP SWELLING 1
389 LIVEDO RETICULARIS 1
390 LYMPHADENOPATHY 1
391 LYMPHOCYTE COUNT DECREASED 1
392 LYMPHOCYTIC HYPOPHYSITIS 1
393 MALFORMATION VENOUS 1
394 MALIGNANT NEOPLASM PROGRESSION 1
395 MALNUTRITION 1
396 MASS 1
397 MASTITIS 1
398 MEMORY IMPAIRMENT 1
399 MENIERE^S DISEASE 1
400 MENTAL DISORDER 1
401 METASTASES TO PERITONEUM 1
402 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1
403 MIGRAINE WITH AURA 1
404 MONOPARESIS 1
405 MOTOR DYSFUNCTION 1
406 MOUTH HAEMORRHAGE 1
407 MYALGIA 1
408 NAIL DISCOLOURATION 1
409 NECROBIOSIS LIPOIDICA DIABETICORUM 1
410 NECROSIS ISCHAEMIC 1
411 NEOVASCULARISATION 1
412 NEURODERMATITIS 1
413 NEUROPATHY PERIPHERAL 1
414 NEUTROPHIL COUNT INCREASED 1
415 NONSPECIFIC REACTION 1
416 NORMAL NEWBORN 1
417 OCCUPATIONAL EXPOSURE TO PRODUCT 1
418 OCULAR HYPERAEMIA 1
419 ONYCHOLYSIS 1
420 OSTEONECROSIS 1
421 OXALOSIS 1
422 PACEMAKER GENERATED ARRHYTHMIA 1
423 PAIN OF SKIN 1
424 PALMOPLANTAR PUSTULOSIS 1
425 PANCREATIC FAILURE 1
426 PARADOXICAL DRUG REACTION 1
427 PARAPARESIS 1
428 PARAPLEGIA 1
429 PARTIAL SEIZURES 1
430 PELVIC VENOUS THROMBOSIS 1
431 PEMPHIGUS 1
432 PERICARDITIS 1
433 PERIPHERAL SENSORY NEUROPATHY 1
434 PHARYNGEAL HYPOAESTHESIA 1
435 PHARYNGEAL OEDEMA 1
436 PHONOPHOBIA 1
437 PHOTOPHOBIA 1
438 PIGMENTATION DISORDER 1
439 PINGUECULA 1
440 PITYRIASIS ROSEA 1
441 PLATELET COUNT DECREASED 1
442 PLATELET COUNT INCREASED 1
443 PNEUMONIA ASPIRATION 1
444 PNEUMONIA VIRAL 1
445 PNEUMONITIS 1
446 POLIOMYELITIS 1
447 POLYDACTYLY 1
448 PORTAL VENOUS GAS 1
449 POST HERPETIC NEURALGIA 1
450 POST PROCEDURAL INFECTION 1
451 PRESBYOPIA 1
452 PROCEDURAL HAEMORRHAGE 1
453 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
454 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
455 PRODUCT ADMINISTRATION ERROR 1
456 PRODUCT CONTAINER ISSUE 1
457 PRODUCT IMPURITY 1
458 PRODUCT PACKAGE ASSOCIATED INJURY 1
459 PROTEIN TOTAL INCREASED 1
460 PROTEINURIA 1
461 PRURITUS GENERALISED 1
462 PSORIATIC ARTHROPATHY 1
463 PULMONARY INFARCTION 1
464 PULSELESS ELECTRICAL ACTIVITY 1
465 PURULENCE 1
466 PUSTULAR PSORIASIS 1
467 PUSTULE 1
468 RASH GENERALISED 1
469 RASH PAPULAR 1
470 RAYNAUD^S PHENOMENON 1
471 RENAL FAILURE 1
472 RETINAL VASCULAR OCCLUSION 1
473 RETINAL VASCULITIS 1
474 RETINOPATHY HYPERTENSIVE 1
475 RIGHT VENTRICULAR DYSFUNCTION 1
476 SARS-COV-1 TEST 1
477 SECRETION DISCHARGE 1
478 SENSE OF OPPRESSION 1
479 SENSORIMOTOR DISORDER 1
480 SENSORY DISTURBANCE 1
481 SEPSIS 1
482 SINUS TACHYCARDIA 1
483 SKIN ABRASION 1
484 SKIN DEPIGMENTATION 1
485 SKIN DISORDER 1
486 SKIN HYPOPIGMENTATION 1
487 SKIN INDURATION 1
488 SKIN INFECTION 1
489 SKIN NEOPLASM EXCISION 1
490 SKIN PLAQUE 1
491 SKIN SWELLING 1
492 SKIN WARM 1
493 SPINAL CORD ISCHAEMIA 1
494 SPINAL CORD OEDEMA 1
495 SPLENIC INFARCTION 1
496 SPLENIC MARGINAL ZONE LYMPHOMA STAGE IV 1
497 SQUAMOUS CELL CARCINOMA 1
498 STAPHYLOCOCCAL SKIN INFECTION 1
499 STEVENS-JOHNSON SYNDROME 1
500 SWELLING FACE 1
501 SWOLLEN TONGUE 1
502 SYNOVIAL RUPTURE 1
503 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1
504 SYSTEMIC LUPUS ERYTHEMATOSUS 1
505 SYSTEMIC SCLERODERMA 1
506 TEMPERATURE DIFFERENCE OF EXTREMITIES 1
507 TEMPOROMANDIBULAR JOINT SYNDROME 1
508 TENDON DISORDER 1
509 THERAPY NON-RESPONDER 1
510 THERMAL BURN 1
511 THROAT IRRITATION 1
512 THROMBOSIS 1
513 TOOTH DISORDER 1
514 TOXIC SKIN ERUPTION 1
515 TOXICITY TO VARIOUS AGENTS 1
516 TRANSAMINASES INCREASED 1
517 TRANSIENT TACHYPNOEA OF THE NEWBORN 1
518 TREMOR 1
519 TRISMUS 1
520 TUBULOINTERSTITIAL NEPHRITIS 1
521 TYPE I HYPERSENSITIVITY 1
522 URINARY TRACT INFECTION 1
523 URINARY TRACT OBSTRUCTION 1
524 URINE OUTPUT DECREASED 1
525 UVEITIS 1
526 VARICOSE VEIN 1
527 VASCULAR PROCEDURE COMPLICATION 1
528 VEIN DISCOLOURATION 1
529 VENOUS THROMBOSIS LIMB 1
530 VENTRICULAR FIBRILLATION 1
531 VESSEL PERFORATION 1
532 WEIGHT INCREASED 1
533 WRONG DRUG ADMINISTERED 1
534 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
535 XANTHOPSIA 1